Home Healthcare Biotechnology Cancer Biologics Market

Cancer Biologics Market Size, Share & Trends Analysis Report By Type (Monoclonal Antibodies, Growth Factor, Blood and Blood Products, Vaccines and Toxoids) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 09, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Cancer Biologics Market Size Analysis
    1. Introduction
    2. Cancer Biologics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Growth Factor 
      3. Blood and Blood Products 
      4. Vaccines and Toxoids
  7. North America Cancer Biologics Market Size Analysis
    1. Introduction
    2. Cancer Biologics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Growth Factor 
      3. Blood and Blood Products 
      4. Vaccines and Toxoids
    3. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    4. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
  8. Europe Cancer Biologics Market Size Analysis
    1. Introduction
    2. Cancer Biologics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Growth Factor 
      3. Blood and Blood Products 
      4. Vaccines and Toxoids
    3. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    4. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    5. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    6. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    7. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    8. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    9. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    10. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    11. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
  9. APAC Cancer Biologics Market Size Analysis
    1. Introduction
    2. Cancer Biologics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Growth Factor 
      3. Blood and Blood Products 
      4. Vaccines and Toxoids
    3. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    4. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    5. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    6. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    7. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    8. Singapore
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
  10. Middle East and Africa Cancer Biologics Market Size Analysis
    1. Introduction
    2. Cancer Biologics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Growth Factor 
      3. Blood and Blood Products 
      4. Vaccines and Toxoids
    3. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    4. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    5. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    6. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    7. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    8. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    9. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
  11. LATAM Cancer Biologics Market Size Analysis
    1. Introduction
    2. Cancer Biologics Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monoclonal Antibodies
      2. Growth Factor 
      3. Blood and Blood Products 
      4. Vaccines and Toxoids
    3. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    4. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    5. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    6. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    7. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
    8. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monoclonal Antibodies
        2. Growth Factor 
        3. Blood and Blood Products 
        4. Vaccines and Toxoids
  12. Competitive Landscape
    1. Cancer Biologics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Hoffmann-La Roche Ltd
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis AG
    3. Eli Lilly and Company
    4. Sanofi
    5. CELGENE CORPORATION
    6. Pfizer Inc.
    7. Bayer AG
    8. Johnson and Johnson Services INC.
    9. Bristol-Myers Squibb Company
    10. Merck & Co. INC.
    11. Amgen Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Cancer Biologics Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 3: North America Cancer Biologics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 4: North America Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 5: U.S. Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 6: Canada Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 7: Europe Cancer Biologics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 8: Europe Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 9: U.K. Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 10: Germany Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 11: France Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 12: Spain Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 13: Italy Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 14: Russia Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 15: Nordic Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 16: Benelux Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 17: Rest of Europe Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 18: APAC Cancer Biologics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 19: APAC Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 20: China Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 21: Korea Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 22: Japan Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 23: India Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 24: Australia Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 25: Singapore Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 26: Taiwan Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 27: South East Asia Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 28: Rest of Asia-Pacific Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 29: Middle East and Africa Cancer Biologics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 30: Middle East and Africa Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 31: UAE Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 32: Turkey Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 33: Saudi Arabia Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 34: South Africa Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 35: Egypt Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 36: Nigeria Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 37: Rest of MEA Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 38: LATAM Cancer Biologics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 39: LATAM Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 40: Brazil Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 41: Mexico Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 42: Argentina Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 43: Chile Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 44: Colombia Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 45: Rest of LATAM Cancer Biologics Market Size and Forecast By Type - 2022-2034 (USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.